OncoCyte Corporation
(OCX)
undefined
undefined%
At close: undefined
2.32
-0.85%
After-hours Dec 13, 2024, 04:00 PM EST
OncoCyte Corporation Analyst Ratings
Total Analysts
3
Consensus Rating
Buy
Price Target
4.25
Upside
81.62
Ratings History
| Analyst | Firm | Rating | Action | Price Target | Date |
Mike Matson (0)
| Needham | Buy | Reiterates | 5 5 | Nov 13, 2024 |
Mike Matson (0)
| Needham | Buy | Reiterates | 5 5 | Oct 15, 2024 |
Mike Matson (0)
| Needham | Buy | Reiterates | 5 5 | Aug 9, 2024 |
Trade Smarter, Not Harder
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options Data
- Instant access to live options data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.